F&P Healthcare underperforming, but there's upside to come

F&P Healthcare underperforming, but there's upside to come
Rebecca Howard
Fisher & Paykel Healthcare may be underperforming the S&P NZX50 of late, but there looks to be plenty of upside.  There are two main reasons. First, countries are battling new outbreaks of covid-19. Second, its equipment is now in place to treat a wide variety of respiratory ailments — not just covid. Hospital products make up around 75 percent of its operating revenue. The stock jumped 48 percent in 2020 as it ramped up manufacturing capacity and hired scores of new staff to meet demand for its hospital hardware pr...

More Editor's Picks

1,600 jobs will go in scaling back school lunches, officials warn
Editor's Picks

1,600 jobs will go in scaling back school lunches, officials warn

Several ministries raise concerns over the plans with the associate education minister.

Cécile Meier 12 Jun 2024
Tesla's profit in NZ falls
Markets

Tesla's profit in NZ falls

Tesla reports lower revenue in NZ even before EV subsidies ended.

Denise McNabb 11 Jun 2024
Fonterra's exit could shake up Aussie dairy industry – again
Primary Sector

Fonterra's exit could shake up Aussie dairy industry – again

New Zealand giant looking to offload a business it bought in 2005.

Riley Kennedy 10 Jun 2024
Medical cannabis regulatory changes too slow, industry says
Markets

Medical cannabis regulatory changes too slow, industry says

The cannabis sector is still waiting for regulatory changes earmarked for the end of 2023.

John Anthony 10 Jun 2024